ICON plc, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries primarily in the United States, Ireland, and rest of Europe. ICON plc specializes in strategic development, management, and analysis of programs that support clinical development from compound selection to Phase I to IV clinical studies. The company's clinical research services include investigator recruitment, study monitoring and data collection, case report form preparation, patient safety monitoring, clinical data management, interactive voice response, electronic patient reported outcomes, medical reporting, patient registries, outcomes research, and health economics. ICON plc clinical research services also comprise strategic analysis and data operation, clinical pharmacology, bioanalysis, immunoassay development, pharmacokinetic and pharmacodynamic analysis, study protocol preparation, regulatory consulting, product development planning, strategic consulting, medical imaging, contract staffing, and electronic endpoint adjudication. In addition, ICON plc provides various laboratory services, including sample analysis, safety testing, microbiology, custom flow cytometry, electronic transmission of test results, and biomarker development. ICON plc was founded in 1990 and is headquartered in Dublin, Ireland.